Nobel Biocare appoints William J. Ryan as Senior Advisor to the Chief Executive Officer
Nobel Biocare announced the appointment of William J. Ryan as Senior Advisor to the Chief Executive Officer. The addition of Bill Ryan, an industry expert with over 20 years' experience, will support Nobel Biocare's emphasis on quality, science and education, as well as its initiatives to strengthen its customer orientation and create and implement sustainable growth strategies.
One important component of these initiatives is the creation of corporate advisory boards, composed of leading clinicians, in each of the three major regions of Europe, Middle East and Africa (EMEA), North America and Asia-Pacific.
Bill Ryan has held various executive positions, over many years, in the field of restorative and esthetic dentistry, and developed strong relationships in the industry. His knowledge, experience and networks will help him facilitate Nobel Biocare's outreach to the clinical community.
Mr. Ryan will operate from a base in the USA. His appointment is effective immediately.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Amorfix recruits ALS leader, Joseph Beckman, Ph.D. to join Scientific Advisory Board
The Netherlands Cancer Institute (NKI) and to-BBB to collaborate on brain delivery of anti-cancer drugs

Coupled Proteins - How human cells react to external signals and further process them

'Trojan horse' anticancer drug disguises itself as fat - Promising system delivers chemo drug straight into tumors with fewer side effects
Oncothyreon announces issuance of patent for PX-867
Hypocapnia
UCB strengthens strategic alliance with WILEX - UCB's position as a strategic investor now represents 18% of WILEX shares
Cardio3 BioSciences Establishes US Subsidiary in Rochester, MN
